Beeharry, N., Landrette, S., Gayle, S., Hernandez, M., Grotzke, J. E., Young, P. R., . . . Lichenstein, H. (2019). LAM-003, a new drug for treatment of tyrosine kinase inhibitor–resistant FLT3-ITD–positive AML. Blood Adv.
Stile di citazione ChicagoBeeharry, Neil, et al. "LAM-003, a New Drug for Treatment of Tyrosine Kinase Inhibitor–resistant FLT3-ITD–positive AML." Blood Adv 2019.
Citazione MLABeeharry, Neil, et al. "LAM-003, a New Drug for Treatment of Tyrosine Kinase Inhibitor–resistant FLT3-ITD–positive AML." Blood Adv 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.